Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly Reports Positive Results From Study of Weight Loss Drug
07:54am, Thursday, 11'th Dec 2025
Eli Lilly's experimental weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a phase three trial involving patients with obesity and knee osteoarthritis.
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
07:39am, Thursday, 11'th Dec 2025
Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its "Metabolic Frontier 2030" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on
Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%
07:12am, Thursday, 11'th Dec 2025
Eli Lily rose above a key level after saying its experimental obesity treatment delivered 23.7% weight loss in a late-stage trial.
Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial
06:49am, Thursday, 11'th Dec 2025
Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a late-stage trial, outperforming its blockbuster drug Zepbound and reinforcing
Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial
06:45am, Thursday, 11'th Dec 2025
Eli Lilly said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injectio
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reduced WOMAC pain scores by up to an av
Eli Lilly and Company $LLY Shares Acquired by Becker Capital Management Inc.
05:24am, Thursday, 11'th Dec 2025
Becker Capital Management Inc. boosted its holdings in Eli Lilly and Company (NYSE: LLY) by 372.4% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 20
Microsoft, Broadcom, Lilly, and Other Stocks That Define ‘Quality' for This Pro
02:00am, Thursday, 11'th Dec 2025
Tom Hancock, a portfolio manager at GMO, favors companies that consistently earn a high return on capital and reinvest in the business.
Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production
04:45pm, Wednesday, 10'th Dec 2025
With demand for weight-loss drugs soaring and an agreement with the White House to produce more medicine in the U.S., Eli Lilly (LLY) is taking steps to boost its domestic output.
Abivax stock pops on Eli Lilly takeover speculation
11:02am, Wednesday, 10'th Dec 2025
Abivax SA (NASDAQ:ABVX, EPA:ABVX), a French biotechnology firm, saw its US-listed shares jump more than 11% on rumors it may be acquired by Eli Lilly and Co (NYSE:LLY). First reported by Reuters, n
French biotech Abivax's shares climb on Eli Lilly bid rumors
05:52am, Wednesday, 10'th Dec 2025
French biotech company Abivax's shares jumped by 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly might be interested in bidding for the business.
Sen. John Boozman Purchases Shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)
02:06am, Wednesday, 10'th Dec 2025
Senator John Boozman (R-Arkansas) recently bought shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA). In a filing disclosed on December 08th, the Senator disclosed that they had bought betwe
Sen. John Boozman Sells iShares MSCI All Country Asia ex Japan ETF (NASDAQ:AAXJ) Stock
02:06am, Wednesday, 10'th Dec 2025
Senator John Boozman (R-Arkansas) recently sold shares of iShares MSCI All Country Asia ex Japan ETF (NASDAQ: AAXJ). In a filing disclosed on December 08th, the Senator disclosed that they had sold be
Sen. John Boozman Purchases Shares of Arista Networks, Inc. (NYSE:ANET)
02:06am, Wednesday, 10'th Dec 2025
Senator John Boozman (R-Arkansas) recently bought shares of Arista Networks, Inc. (NYSE: ANET). In a filing disclosed on December 08th, the Senator disclosed that they had bought between $1,001 and $1
iShares MSCI EAFE ETF (NYSEARCA:EFA) Stock Unloaded Sen. John Boozman
02:06am, Wednesday, 10'th Dec 2025
Senator John Boozman (R-Arkansas) recently sold shares of iShares MSCI EAFE ETF (NYSEARCA:EFA). In a filing disclosed on December 08th, the Senator disclosed that they had sold between $1,001 and $15,
